Design of new small molecules derived from indolin-2-one as potent TRKs inhibitors using a computer-aided drug design approach

Abstract

Tropomyosin receptor kinase (TRKs) enzymes are responsible for cancers associated with the neurotrophic tyrosine kinase receptor gene fusion and are identified as effective targets for anticancer d...